BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,000 | +16.7% | 5,903 | -7.2% | 0.00% | – |
| Q3 2019 | $6,000 | +50.0% | 6,360 | +295.0% | 0.00% | – |
| Q2 2019 | $4,000 | -20.0% | 1,610 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | 0.0% | 1,610 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -54.5% | 1,610 | 0.0% | 0.00% | – |
| Q3 2018 | $11,000 | +120.0% | 1,610 | +163.9% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 610 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | +25.0% | 610 | +19.6% | 0.00% | – |
| Q4 2017 | $4,000 | -42.9% | 510 | -14.4% | 0.00% | – |
| Q3 2017 | $7,000 | +16.7% | 596 | +20.2% | 0.00% | – |
| Q2 2017 | $6,000 | 0.0% | 496 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | -33.3% | 496 | -9.0% | 0.00% | – |
| Q4 2016 | $9,000 | -18.2% | 545 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | +120.0% | 545 | +32.9% | 0.00% | – |
| Q2 2016 | $5,000 | +25.0% | 410 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | – | 410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 205,990 | $2,670,000 | 1.83% |
| Baker Brothers Advisors | 4,865,647 | $63,059,000 | 0.66% |
| QVT Financial LP | 507,939 | $6,583,000 | 0.45% |
| MCDANIEL TERRY & CO | 84,612 | $1,097,000 | 0.25% |
| Virtus ETF Advisers LLC | 20,302 | $263,000 | 0.20% |
| Vident Investment Advisory, LLC | 54,072 | $701,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 326,573 | $4,232,000 | 0.09% |
| Highlander Capital Management, LLC | 6,500 | $84,000 | 0.08% |
| TFS CAPITAL LLC | 21,784 | $282,000 | 0.05% |
| Tekla Capital Management LLC | 60,000 | $778,000 | 0.03% |